Published in J Magn Magn Mater on May 01, 2009
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res (2009) 1.17
Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry. Phys Med Biol (2010) 1.06
Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors. Breast Cancer Res (2011) 1.01
Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. Contrast Media Mol Imaging (2012) 0.96
Magnetic Relaxometry with an Atomic Magnetometer and SQUID Sensors on Targeted Cancer Cells. J Magn Magn Mater (2012) 0.88
Nanopharmaceuticals (part 2): products in the pipeline. Int J Nanomedicine (2015) 0.86
Modeling the efficiency of a magnetic needle for collecting magnetic cells. Phys Med Biol (2014) 0.75
Giant Magnetoresistive Biosensors for Time-Domain Magnetorelaxometry: A Theoretical Investigation and Progress Toward an Immunoassay. Sci Rep (2017) 0.75
Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc Natl Acad Sci U S A (2000) 2.52
A biomagnetic system for in vivo cancer imaging. Phys Med Biol (2005) 1.71
Determination of energy barrier distributions of magnetic nanoparticles by temperature dependent magnetorelaxometry. Nanotechnology (2003) 1.14
Magnetic needles and superparamagnetic cells. Phys Med Biol (2007) 1.03
Clinical and biological significance of CD34 expression in acute leukemia. J Biol Regul Homeost Agents (2001) 1.03
Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol (2008) 3.20
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12
Isolation of quiescent and nonquiescent cells from yeast stationary-phase cultures. J Cell Biol (2006) 2.60
In vivo effects of a GPR30 antagonist. Nat Chem Biol (2009) 2.39
Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol (2007) 1.86
Drug Repurposing from an Academic Perspective. Drug Discov Today Ther Strateg (2011) 1.68
The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem (2003) 1.66
GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol (2009) 1.63
Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target (2003) 1.58
Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis. Leuk Lymphoma (2013) 1.58
Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J (2006) 1.52
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol (2011) 1.42
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood (2010) 1.40
Alpha4beta1 integrin affinity changes govern cell adhesion. J Biol Chem (2003) 1.20
Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2007) 1.19
CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol (2005) 1.18
Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood (2006) 1.17
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res (2009) 1.17
Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J Liposome Res (2003) 1.16
Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. J Med Chem (2010) 1.16
Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. Curr Protein Pept Sci (2005) 1.16
High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters. Assay Drug Dev Technol (2008) 1.14
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia. J Clin Oncol (2010) 1.14
Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging. J Nanopart Res (2011) 1.12
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood (2009) 1.11
Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A (2008) 1.08
Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry. Phys Med Biol (2010) 1.06
Magnetic needles and superparamagnetic cells. Phys Med Biol (2007) 1.03
GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology (2013) 1.03
Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples. Br J Haematol (2007) 1.03
Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors. Breast Cancer Res (2011) 1.01
Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection. J Magn Magn Mater (2007) 1.00
Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J Immunol (2007) 0.98
Relationship between molecular and cellular dissociation rates for VLA-4/VCAM-1 interaction in the absence of shear stress. Biophys J (2004) 0.97
Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension (2011) 0.97
Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. Contrast Media Mol Imaging (2012) 0.96
High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent. J Biomol Screen (2008) 0.95
Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol (2009) 0.93
T lymphocytes as potential therapeutic drug carrier for cancer treatment. Int J Pharm (2006) 0.90
Speaking the right language: the scientific method as a framework for a continuous quality improvement program within academic medical research compliance units. Acad Med (2008) 0.89
In situ transmission electron microscopy observation of pulverization of aluminum nanowires and evolution of the thin surface Al2O3 layers during lithiation-delithiation cycles. Nano Lett (2011) 0.88
Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters. Anal Biochem (2013) 0.88
Magnetic Relaxometry with an Atomic Magnetometer and SQUID Sensors on Targeted Cancer Cells. J Magn Magn Mater (2012) 0.88
Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade. Antimicrob Agents Chemother (2008) 0.88
Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays. Anal Biochem (2010) 0.87
Quantification of specific bindings of biomolecules by magnetorelaxometry. J Nanobiotechnology (2008) 0.87
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells. Breast Cancer Res Treat (2010) 0.87
Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers. J Nucl Med (2008) 0.86
The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides. J Mol Graph Model (2004) 0.86
Amelioration of ischemia-reperfusion injury with cyclic peptide blockade of ICAM-1. Am J Physiol Heart Circ Physiol (2002) 0.85
Magnetic Properties of Nanoparticles Useful for SQUID Relaxometry in Biomedical Applications. J Magn Magn Mater (2011) 0.84
Evaluation of the tolerance and distribution of intravenously applied ferrofluid particles of 250 and 500 nm size in an animal model. J Drug Target (2009) 0.83
Rapid detection of human immunodeficiency virus types 1 and 2 by use of an improved piezoelectric biosensor. J Clin Microbiol (2013) 0.82
Templateless assembly of molecularly aligned conductive polymer nanowires: a new approach for oriented nanostructures. Chemistry (2003) 0.82
Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses. Chem Biol Drug Des (2007) 0.82
A selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometry. J Biomol Screen (2012) 0.82
Real-time analysis of the inside-out regulation of lymphocyte function-associated antigen-1 revealed similarities to and differences from very late antigen-4. J Biol Chem (2011) 0.82
Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung. Pharm Res (2012) 0.82
Phage display selection of cyclic peptides that inhibit Andes virus infection. J Virol (2009) 0.81
Structural and Magnetic Characterization of Superparamagnetic Iron Platinum Nanoparticle Contrast Agents for Magnetic Resonance Imaging. J Vac Sci Technol B Nanotechnol Microelectron (2012) 0.81
Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents. ACS Chem Biol (2010) 0.81
Microenvironmental control of the breast cancer cell cycle. Anat Rec (Hoboken) (2012) 0.80